NEW YORK (GenomeWeb News) – Exact Sciences said after the close of the market Wednesday that it has launched a $125 million public offering of common stock.

The Madison, Wis.-based molecular diagnostics developer didn't say how many shares it intends to offer.

Its stock closed at $14.25 in Wednesday trade on the Nasdaq but was down around 5 percent at $13.49 Thursday morning.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.